Tom Rosenbloom hired as President

FreMon Scientific announces the appointment of Thomas A. Rosenbloom as President and Chief Legal Officer.

He will serve on the company’s leadership team, reporting directly to CEO Dr. Farideh Bischoff.

Mr. Rosenbloom’s experience includes over 11 years as Executive Vice President, General Counsel, and Secretary of CYS, Investments, Inc., a multi-billion dollar NYSE specialty finance company where he had significant operational, board, and business development responsibilities and helped grow a $100M private mortgage-REIT into a $2.7B+ NYSE-listed company. Mr. Rosenbloom served as an integral contributor to significant growth at CYS through its IPO and follow-on equity offerings. He provided exceptional oversight and management of an extremely active and engaged Board. Prior to CYS, Mr. Rosenbloom spent more than nine years as a partner at Foley & Lardner, where he had a corporate, securities, and M&A practice. He brings over 30 years of experience working with entrepreneurs, founders, and growth businesses to FreMon Scientific.

Mr. Rosenbloom is a founding Director of FreMon Scientific, having served as a pre-incorporation advisor to the co-founders Fred Thacher and Moni Shavit.

“I am pleased to welcome Tom on a daily basis to FreMon Scientific and to our leadership team,” said Dr. Farideh Bischoff, the company’s CEO. “A seasoned legal executive with extensive management and operational experience, Tom’s legal acumen, dedication to talent development and deep understanding of FreMon Scientific’s history and mission will be invaluable to us as we continue to drive production and initial sales of our controlled thawing products around the world.”

“I am delighted to be joining FreMon Scientific in an executive capacity. As a director of the Company since incorporation in 2013, I have been closely involved in the company’s growth, progress, and efforts to date,” said Mr. Rosenbloom.

“FreMon Scientific has achieved remarkable success and progress in developing an exciting, new, disruptive medical device; yet, there is much work to be done to achieve commercial viability and success. I look forward to working with Farideh, Fred, Moni, and the entire FreMon Scientific team on a full-time basis to achieve our goals, and to create great value for our investors while bringing a remarkable, impactful, live-changing device to market.”

Mr. Rosenbloom earned his B.A. from the University of Wisconsin-Madison and his Juris Doctor from the Boston University School of Law.